In conclusion, we demonstrate that FOXO3 negatively regulated RASIP1 facilitates growth and invasion of DLBCL cells, provides novel diagnostic markers and therapeutic targets for DLBCL in clinic. This evidence concerns the gene FOXO3 and diffuse large B-cell lymphoma.